The Cancer Chemotherapeutic Paclitaxel Increases Human and Rodent Sensory Neuron Responses to TRPV1 by Activation of TLR4

Peripheral neuropathy is dose limiting in paclitaxel cancer chemotherapy and can result in both acute pain during treatment and chronic persistent pain in cancer survivors. The hypothesis tested was that paclitaxel produces these adverse effects at least in part by sensitizing transient receptor pot...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Neurosci
Autori principali: Li, Yan, Adamek, Pavel, Zhang, Haijun, Tatsui, Claudio Esteves, Rhines, Laurence D., Mrozkova, Petra, Li, Qin, Kosturakis, Alyssa K., Cassidy, Ryan M., Harrison, Daniel S., Cata, Juan P., Sapire, Kenneth, Zhang, Hongmei, Kennamer-Chapman, Ross M., Jawad, Abdul Basit, Ghetti, Andre, Yan, Jiusheng, Palecek, Jiri, Dougherty, Patrick M.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Society for Neuroscience 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4588613/
https://ncbi.nlm.nih.gov/pubmed/26424893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.1956-15.2015
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi